936 Results

People

  1. Tap
    Tap
  2. D'Angelo
    D'Angelo
  3. Gounder
    Gounder
  4. Chi
    Chi
  5. Dickson
    Dickson
  6. Antonescu
    Antonescu
  7. Keohan
    Keohan
  8. Singer
    Singer
  9. Kelly
    Kelly
  10. Qin
    Qin

Groups

  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)
  7. Department of Pathology and Laboratory Medicine (237)
  8. Human Oncology and Pathogenesis Program (232)
  9. Surgery (199)
  10. Sarcoma Surgeons (142)
  1. "Sarcoma Service"
Formats
  1. Journal Article (444)
  2. Meeting Abstract (429)
  3. Review (26)
  4. Editorial (8)
  5. Guidelines (8)
  6. Book Section (6)
  7. Miscellaneous (6)
  8. Research Letter (6)
  9. Correspondence (2)
  10. Book Whole (1)
Groups
  1. Department of Medicine (936)
  2. Sarcoma Service (936)
  3. Solid Tumor Oncology Division (936)
  4. GSK Faculty (336)
  5. Tow Center for Developmental Oncology (TCDO) (304)
  6. Hematologic Malignancies, Division of (289)

More Groups

People
  1. William Tap (372)
  2. Sandra D'Angelo (252)
  3. Mrinal Gounder (228)
  4. Ping Chi (172)
  5. Mark Dickson (169)
  6. Cristina Antonescu (135)

More People

Years
  1. 2025 (27)
  2. 2024 (87)
  3. 2023 (79)
  4. 2022 (116)
  5. 2021 (76)
  6. 2020 (90)

More Years

Publications
  1. Journal of Clinical Oncology (272)
  2. Annals of Oncology (70)
  3. Clinical Cancer Research (60)
  4. Cancer Research (31)
  5. Journal for ImmunoTherapy of Cancer (25)
  6. Cancer (19)

More Publications

Publishers
  1. American Society of Clinical Oncology (286)
  2. American Association for Cancer Research (107)
  3. Oxford University Press (91)
  4. Elsevier Inc. (59)
  5. Nature Publishing Group (41)
  6. Springer (40)

More Publishers

Results (936)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • The emerging role of immunotherapy for the treatment of sarcoma
    Review

    Klemen, N. D.; Kelly, C. M.; Bartlett, E. K.
    Journal of Surgical Oncology (2021)

    Fulltext@MSK | Save
  • Population pharmacokinetic analysis of pexidartinib in healthy subjects and patients with tenosynovial giant cell tumor or other solid tumors
    Journal Article

    Yin, O.; Wagner, A. J.; Kang, J.; Knebel, W.; Zahir, H.; van de Sande, M.; Tap, W. D.; Gelderblom, H.; Healey, J. H.; Shuster, D.; more...
    Journal of Clinical Pharmacology (2021)

    Fulltext@MSK | Save
  • Long-term outcomes of pexidartinib in tenosynovial giant cell tumors
    Journal Article

    Gelderblom, H.; Wagner, A. J.; Tap, W. D.; Palmerini, E.; Wainberg, Z. A.; Desai, J.; Healey, J. H.; van de Sande, M. A. J.; Bernthal, N. M.; Staals, E. L.; more...
    Cancer (2021)

    Fulltext@MSK | Save
  • Oncohistone mutations enhance chromatin remodeling and alter cell fates
    Journal Article

    Bagert, J. D.; Mitchener, M. M.; Patriotis, A. L.; Dul, B. E.; Wojcik, F.; Nacev, B. A.; Feng, L.; Allis, C. D.; Muir, T. W.
    Nature Chemical Biology (2021)

    Fulltext@MSK | Save
  • Selinexor versus doxorubicin in dedifferentiated liposarcoma PDXs: Evidence of greater activity and apoptotic response dependent on p53 nuclear accumulation and survivin down‐regulation
    Journal Article

    Zuco, V.; Pasquali, S.; Tortoreto, M.; Brich, S.; Percio, S.; Dagrada, G. P.; Colombo, C.; Sanfilippo, R.; Lauricella, C.; Gounder, M.; more...
    Journal of Experimental & Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Direct evidence that the GPCR CysLTR2 mutant causative of uveal melanoma is constitutively active with highly biased signaling
    Journal Article

    Ceraudo, E.; Horioka, M.; Mattheisen, J. M.; Hitchman, T. D.; Moore, A. R.; Kazmi, M. A.; Chi, P.; Chen, Y.; Sakmar, T. P.; Huber, T.
    Journal of Biological Chemistry (2021)

    Fulltext@MSK | Save
  • Combined inhibition of Gα(q) and MEK enhances therapeutic efficacy in uveal melanoma
    Journal Article

    Hitchman, T. D.; Bayshtok, G.; Ceraudo, E.; Moore, A. R.; Lee, C.; Jia, R.; Wang, N.; Pachai, M. R.; Shoushtari, A. N.; Francis, J. H.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • FDA Oncology Center of Excellence project renewal: Engaging the oncology community to update product labeling for older oncology drugs
    Review

    Kluetz, P. G.; Keegan, P.; Demetri, G. D.; Thornton, K.; Sul, J.; Kim, J.; Katzen, H.; Burke, L. B.; Harvey, R. D.; Alebachew, E.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Composite grading algorithm for the National Cancer Institute’s Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events (PRO-CTCAE)
    Journal Article

    Basch, E.; Becker, C.; Rogak, L. J.; Schrag, D.; Reeve, B. B.; Spears, P.; Smith, M. L.; Gounder, M. M.; Mahoney, M. R.; Schwartz, G. K.; more...
    Clinical Trials (2021)

    Fulltext@MSK | Save
  • Intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory advanced solid tumors
    Journal Article

    Janku, F.; Zhang, H. H.; Pezeshki, A.; Goel, S.; Murthy, R.; Wang-Gillam, A.; Shepard, D. R.; Helgason, T.; Masters, T.; Hong, D. S.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save